Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dexmedetomidine + ropivacaine + ketorolac
- Development stage
- Unknown
- Lead developer
- Massachusetts General Hospital
- Modality
- Small Molecules
- Administration
- Local Infiltration
01
Overview
This multimodal analgesic combination consists of dexmedetomidine, ropivacaine, and ketorolac, developed by Massachusetts General Hospital for the management of postoperative pain. It is administered via a rectus sheath block to provide localized pain relief and reduce the consumption of systemic opioids following surgery. Ropivacaine acts as a long-acting local anesthetic by blocking sodium channels, ketorolac provides anti-inflammatory and analgesic effects through the inhibition of cyclooxygenase enzymes, and dexmedetomidine, an alpha-2 adrenergic agonist, serves as an adjuvant to prolong the duration of the block and enhance the sedative/analgesic effect.
- Other names
- Multimodal analgesia
02
Targets
ADRA2A (α2A)PGHS-1 (Prostaglandin G/H Synthase 1)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on dexmedetomidine + ropivacaine + ketorolac.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dexmedetomidine + ropivacaine + ketorolac.